Cetera Advisor Networks’s Viking Therapeutics VKTX Stock Holding History

Cetera Advisor Networks’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.3M	Sell	15,868 -7,380	-32%	-$328K	0.01%	1289
2023 Q4	$433K	Buy	23,248 +4,600	+25%	+$60.2K	﹤0.01%	2000
2023 Q3	$206K	Buy	18,648 +550	+3%	+$7.87K	﹤0.01%	2408
2023 Q2	$293K	Buy	18,098 +220	+1%	+$4.61K	﹤0.01%	2100
2023 Q1	$298K	Buy	17,878 +2,167	+14%	+$22.4K	﹤0.01%	2061
2022 Q4	$148K	Buy	15,711 +3,152	+25%	+$14.1K	﹤0.01%	2330
2022 Q3	$34K	Hold	12,559	–	–	﹤0.01%	2034
2022 Q2	$36K	Buy	+12,559	New	+$31.1K	﹤0.01%	2014

Other funds holding VKTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Cetera Advisor Networks's VKTX Position: Q1 2024 in Review

Cetera Advisor Networks reduced its Viking Therapeutics (VKTX) stake by 32% in Q1 2024, selling an estimated $328K and leaving 15,868 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #1289.

Cetera Advisor Networks first reported a position in VKTX in Q2 2022 and has held it in 8 quarters since. 375 funds tracked by Wall St. Rank hold VKTX as of Q1 2024.

Cetera Advisor Networks held 15,868 shares of Viking Therapeutics worth $1.3M as of Q1 2024.
Cetera Advisor Networks sold 7,380 Viking Therapeutics shares in Q1 2024, an estimated $328K.
Viking Therapeutics made up 0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1289 holding.
Cetera Advisor Networks first reported a position in Viking Therapeutics in Q2 2022 and has held it in 8 quarters since.
375 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.